NOXXON PHARMA NV (ALNOX.PA) Stock Price, Quote, News and Overview
EPA:ALNOX - Euronext Paris - Matif - NL0012044762 - Common Stock - Currency: EUR
ALNOX.PA Quote, Performance and Key Statistics
EPA:ALNOX (7/18/2022, 7:00:00 PM)
0.041
-0.01 (-18%)
The current stock price of ALNOX.PA is 0.041 EUR. In the past month the price decreased by -38.99%. In the past year, price decreased by -88.28%.
ALNOX.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.85 | 294.99B | ||
| AMG.DE | AMGEN INC | 14.38 | 138.46B | ||
| 1AMGN.MI | AMGEN INC | 14.07 | 135.48B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 14.35 | 119.24B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.26 | 118.47B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 101.78B | ||
| ARGX.BR | ARGENX SE | 109.02 | 30.69B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 22.03B | ||
| IDP.DE | BIOGEN INC | 8.34 | 16.68B | ||
| 1EXEL.MI | EXELIXIS INC | N/A | 9.81B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.63B | ||
| 0QF.DE | MODERNA INC | N/A | 8.96B |
Related stock screener links
About ALNOX.PA
Company Profile
NOXXON Pharma NV operates as a clinical-stage biopharmaceutical company, which focuses on cancer treatment. The company is headquartered in Berlin, Berlin and currently employs 13 full-time employees. The company went IPO on 2018-09-10. The firm's main product is the Spiegelmer platform. Spiegelmers are a variant of a drug class called aptamers, which are based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) and are built on a backbone of mirror-image RNA or DNA - L-stereoisomers. The firm's lead candidate, NOX-A12, is under development as a combination therapy for a number of cancer indications using immuno-oncology approaches, such as immune checkpoint inhibition and current standards of care, such as chemotherapy and radiotherapy. The firm also develops NOX-E36, which is aimed at the treatment of complications arising from diabetic nephropathy.
Company Info
NOXXON PHARMA NV
Max-Dohrn-Str. 8-10
Berlin BERLIN DE
Employees: 13
Phone: 49307262470.0
NOXXON PHARMA NV / ALNOX.PA FAQ
What is the stock price of NOXXON PHARMA NV today?
The current stock price of ALNOX.PA is 0.041 EUR. The price decreased by -18% in the last trading session.
What is the ticker symbol for NOXXON PHARMA NV stock?
The exchange symbol of NOXXON PHARMA NV is ALNOX and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ALNOX.PA stock listed?
ALNOX.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for NOXXON PHARMA NV stock?
10 analysts have analysed ALNOX.PA and the average price target is 7.39 EUR. This implies a price increase of 17919.93% is expected in the next year compared to the current price of 0.041. Check the NOXXON PHARMA NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NOXXON PHARMA NV worth?
NOXXON PHARMA NV (ALNOX.PA) has a market capitalization of 3.05M EUR. This makes ALNOX.PA a Nano Cap stock.
How many employees does NOXXON PHARMA NV have?
NOXXON PHARMA NV (ALNOX.PA) currently has 13 employees.
What are the support and resistance levels for NOXXON PHARMA NV (ALNOX.PA) stock?
NOXXON PHARMA NV (ALNOX.PA) has a resistance level at 0.05. Check the full technical report for a detailed analysis of ALNOX.PA support and resistance levels.
Should I buy NOXXON PHARMA NV (ALNOX.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALNOX.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALNOX.PA, evaluating the profitability, health, valuation and growth aspects
- NOXXON PHARMA NV (ALNOX.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NOXXON PHARMA NV (ALNOX.PA) Sales and EPS estimates to see what analysts future expectations are.
- NOXXON PHARMA NV (ALNOX.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NOXXON PHARMA NV (ALNOX.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NOXXON PHARMA NV (ALNOX.PA) Stock Chart to make your own analysis
- NOXXON PHARMA NV (ALNOX.PA) Latest news and press-releases to stay up to date.
Does NOXXON PHARMA NV (ALNOX.PA) stock pay dividends?
ALNOX.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of NOXXON PHARMA NV (ALNOX.PA)?
NOXXON PHARMA NV (ALNOX.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).
ALNOX.PA Technical Analysis
ALNOX.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALNOX.PA. ALNOX.PA may be in some trouble as it scores bad on both profitability and health.
ALNOX.PA Financial Highlights
Over the last trailing twelve months ALNOX.PA reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS increased by 40.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -147.9% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
ALNOX.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to ALNOX.PA. The Buy consensus is the average rating of analysts ratings from 10 analysts.